ソース:[1] BCLI:第3b相ENDURANCE治験の開始に注力... (https://finance.yahoo.com/news/bcli-focused-i ...)[2] BrainStorm、第3b相治験開始のFDA承認を取得... (https://ir.brainstorm-cell.com/2025-05-19-Bra ...)[3] Brainstorm、ALS治験向けNurOwnのINDを提出 - LinkedIn (https://www.linkedin.com/posts/brainstorm-cel ...)